The role of pharmacotherapy in the treatment of metabolic syndrome
Alvaro Carlos Galdos Riveros, Eliane Souza Moura, Evillin Da Silva Lima
The role of pharmacotherapy in the treatment of metabolic syndrome
Alvaro Carlos Galdos Riveros, Eliane Souza Moura, Evillin Da Silva Lima
Metabolic syndrome (MS) can be characterised by a group of risk factors for cardiovascular disease, related to central fat distribution and insulin resistance. Obesity is growing rapidly and is directly related to MetS and some of its complications include type II diabetes mellitus, hypercholesterolaemia and hypertension. Treatment for MetS is based mainly on lifestyle changes to reduce weight and, if necessary, drug therapy to treat hypertension, diabetes mellitus and dyslipidaemia, as these are considered risk factors for cardiovascular disease (CVD).
This item is not currently in-stock. It can be ordered online and is expected to ship in approx 2 weeks
Our stock data is updated periodically, and availability may change throughout the day for in-demand items. Please call the relevant shop for the most current stock information. Prices are subject to change without notice.
Sign in or become a Readings Member to add this title to a wishlist.